US 8524720
Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors
granted A61PA61P25/18A61P25/28
Quick answer
US patent 8524720 (Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P25/18, A61P25/28, A61P3/10, A61P35/00